As such, VEGF contribution to PPHN is, at least in part, mediated by decreased NO-cGMP signaling (Figure 2), since VEGF increases NO release in vivo, leading to pulmonary vasodilation (144). This evidence concerns the gene VEGFA and persistent fetal circulation syndrome.